EFSA Journal (Sep 2023)

Modification of the existing maximum residue levels for mefentrifluconazole in various commodities

  • EFSA (European Food Safety Authority),
  • Giulia Bellisai,
  • Giovanni Bernasconi,
  • Luis Carrasco Cabrera,
  • Irene Castellan,
  • Monica delAguila,
  • Lucien Ferreira,
  • German Giner Santonja,
  • Luna Greco,
  • Samira Jarrah,
  • Renata Leuschner,
  • Javier Martinez Perez,
  • Ileana Miron,
  • Stefanie Nave,
  • Ragnor Pedersen,
  • Hermine Reich,
  • Silvia Ruocco,
  • Miguel Santos,
  • Alessia Pia Scarlato,
  • Anne Theobald,
  • Manuela Tiramani,
  • Alessia Verani

DOI
https://doi.org/10.2903/j.efsa.2023.8237
Journal volume & issue
Vol. 21, no. 9
pp. n/a – n/a

Abstract

Read online

Abstract In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant BASF Agro B.V. Arnhem (NL) Freienbach Branch submitted a request to the competent national authority in Austria to modify the existing maximum residue levels (MRLs) for the active substance mefentrifluconazole in various crops and swine liver and other swine products. The data submitted in support of the request were found to be sufficient to derive MRL proposals. Adequate analytical methods for enforcement are available to control the residues of mefentrifluconazole in the plant commodities under consideration and in animal matrices at the validated limit of quantification (LOQ) of 0.01 mg/kg. New data relevant to the data gaps on storage stability and feeding studies of triazole derivative metabolites (TDMs), that were identified during the peer review of confirmatory data of the TDMs, were submitted in support of the present MRL application. Based on the risk assessment results, EFSA concluded that the short‐term and long‐term intake of residues resulting from the use of mefentrifluconazole according to the reported agricultural practices is unlikely to present a risk to consumer health. EFSA noted a narrow safety margin with regard to acute exposure to mefentrifluconazole residues from the intake of spinaches if residues occur at the level of the proposed MRL. EFSA also performed an indicative risk assessment for the TDMs based on uses of mefentrifluconazole only. The estimated exposure for TDMs did not exceed the toxicological reference values.

Keywords